Literature DB >> 24867868

Sex-related differences in migraine.

Cinzia Finocchi1, Laura Strada.   

Abstract

This paper reviews sex-related differences in migraine epidemiology, symptoms, natural history and co-morbid disorders. Migraine is more than twice as common in females as in males, and women experience more frequent, longer lasting and more painful attacks, have more disability and a risk of transition from episodic to chronic migraine greater than men, but the mechanisms behind these differences are still poorly understood. The role of sex hormones, genes, and the differences in brain function and structure are discussed. Finally, we evaluate the many gender-related questions about treatment of migraine in women. In future research data should be analyzed separately for men and women to ensure that differences between the sexes could be identified.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867868     DOI: 10.1007/s10072-014-1772-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  58 in total

Review 1.  Safety of sumatriptan in pregnancy: a review of the data so far.

Authors:  Elizabeth Loder
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Authors:  Dawn C Buse; Elizabeth W Loder; Jennifer A Gorman; Walter F Stewart; Michael L Reed; Kristina M Fanning; Daniel Serrano; Richard B Lipton
Journal:  Headache       Date:  2013-06-28       Impact factor: 5.887

3.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

4.  Migrainous infarction: a Nordic multicenter study.

Authors:  K Laurell; V Artto; L Bendtsen; K Hagen; M Kallela; E Laudon Meyer; J Putaala; E Tronvik; J-A Zwart; M Linde
Journal:  Eur J Neurol       Date:  2011-03-18       Impact factor: 6.089

5.  Clinical and personality features of allodynic migraine.

Authors:  V C d'Agostino; E Francia; V Licursi; R Cerbo
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

6.  Age- and gender-related differences in the cortical anatomical network.

Authors:  Gaolang Gong; Pedro Rosa-Neto; Felix Carbonell; Zhang J Chen; Yong He; Alan C Evans
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

7.  A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.

Authors:  Stephen D Silberstein; Arthur H Elkind; Curtis Schreiber; Charlotte Keywood
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

8.  Association of oestrogen-receptor gene (ESR1) polymorphisms with migraine in the large Norfolk Island pedigree.

Authors:  Astrid J Rodriguez-Acevedo; Bridget H Maher; Rodney A Lea; Miles Benton; Lyn R Griffiths
Journal:  Cephalalgia       Date:  2013-05-14       Impact factor: 6.292

9.  Sex differences in the transmission of migraine.

Authors:  N C P Low; L Cui; K R Merikangas
Journal:  Cephalalgia       Date:  2007-08       Impact factor: 6.292

10.  Migraine and hemorrhagic stroke: a meta-analysis.

Authors:  Simona Sacco; Raffaele Ornello; Patrizia Ripa; Francesca Pistoia; Antonio Carolei
Journal:  Stroke       Date:  2013-10-01       Impact factor: 7.914

View more
  20 in total

Review 1.  Migrainomics - identifying brain and genetic markers of migraine.

Authors:  Dale R Nyholt; David Borsook; Lyn R Griffiths
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

Review 2.  Association Between Obesity and Migraine in Women.

Authors:  Jelena M Pavlovic; Julio R Vieira; Richard B Lipton; Dale S Bond
Journal:  Curr Pain Headache Rep       Date:  2017-08-25

Review 3.  Headache and Its Management in Patients With Multiple Sclerosis.

Authors:  Farhat Husain; Gabriel Pardo; Meheroz Rabadi
Journal:  Curr Treat Options Neurol       Date:  2018-03-24       Impact factor: 3.598

4.  Association of Migraine Headaches With Suicidal Ideation Among Pregnant Women in Lima, Peru.

Authors:  Lauren E Friedman; Bizu Gelaye; Marta B Rondon; Sixto E Sanchez; B Lee Peterlin; Michelle A Williams
Journal:  Headache       Date:  2016-03-26       Impact factor: 5.887

5.  Efficacy of ultrasound-guided greater occipital nerve pulsed radiofrequency therapy in chronic refractory migraine.

Authors:  Derya Guner; Can Eyigor
Journal:  Acta Neurol Belg       Date:  2022-06-02       Impact factor: 2.396

Review 6.  [Pain medicine from intercultural and gender-related perspectives].

Authors:  M Schiltenwolf; E M Pogatzki-Zahn
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

7.  Association Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA.

Authors:  Lauren E Friedman; Qiu-Yue Zhong; Bizu Gelaye; Michelle A Williams; B Lee Peterlin
Journal:  Headache       Date:  2017-11-29       Impact factor: 5.887

8.  A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.

Authors:  Stefania Chiappini; Fabrizio Schifano
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

9.  Sex Differences of Migraine: Results of a Nationwide Home-based Study in Turkey.

Authors:  Emel Oğuz Akarsu; Betül Baykan; Mustafa Ertaş; Mehmet Zarifoğlu; Elif Kocasoy Orhan; Sabahattin Saip; Aksel Siva; Ayşe Emel Önal; Necdet Karli
Journal:  Noro Psikiyatr Ars       Date:  2019-09-26       Impact factor: 1.339

10.  Selective targeting of peripheral cannabinoid receptors prevents behavioral symptoms and sensitization of trigeminal neurons in mouse models of migraine and medication overuse headache.

Authors:  Toru Yamamoto; Yatendra Mulpuri; Mikhail Izraylev; Qianyi Li; Menooa Simonian; Christian Kramme; Brian L Schmidt; Herbert H Seltzman; Igor Spigelman
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.